CN104306845A - Traditional Chinese medicine composition for treating hyperosteogeny and application thereof - Google Patents
Traditional Chinese medicine composition for treating hyperosteogeny and application thereof Download PDFInfo
- Publication number
- CN104306845A CN104306845A CN201410650325.4A CN201410650325A CN104306845A CN 104306845 A CN104306845 A CN 104306845A CN 201410650325 A CN201410650325 A CN 201410650325A CN 104306845 A CN104306845 A CN 104306845A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- chinese medicine
- medicine composition
- hyperosteogeny
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/62—Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/237—Notopterygium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/27—Asclepiadaceae (Milkweed family), e.g. hoya
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/716—Clematis (leather flower)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/85—Verbenaceae (Verbena family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a traditional Chinese medicine composition for treating hyperosteogeny, and belongs to the technical field of traditional Chinese medicine and pharmacy. The traditional Chinese medicine composition is prepared from the following traditional Chinese medicine raw materials: safflower, synurus deltoides, radix cynanchi bungei, prepared rehmannia roots, premna urticifolia rehd, clematis roots, delavay ampelopsis roots, lumbricus, litsea rotundifolia, Yunnan incised notopterygium rhizomes or roots, stahlianthus hainanensis, ardisia villosa, three-leaf lotus, lycopodiumfargesii grass, chlorophytum comosum and licorice roots. The traditional Chinese medicine composition has the efficacies of promoting blood circulation for removing blood stasis and dredging meridians, is used fir treating the hyperosteogeny, and has the advantages that the curative effect is good, the traditional Chinese medicine composition takes effect quickly and the recurrence rate is low.
Description
Technical field
The invention belongs to technical field of Chinese medicine, be specifically related to a kind of Chinese medicine composition for the treatment of hyperosteogeny.
Background technology
Bone matrix hyperplasia is also called hyperplastic osteoarthritis, osteoarthritis (OA), degenerative joint disease, senile arthritis, hypertrophiarthritis, soft tissue degeneration, the degeneration such as cartilage, intervertebral disc, ligament owing to forming joint, joint margins forms bony spur, synovial membrane plumpness waits change, and occurs osteoclasia, causes insecondary hyperosteogeny, cause joint deformity, when being subject to abnormal load, cause arthralgia, a kind of disease of the symptoms such as limitation of activity.Divide constitutional and Secondary cases two kinds.Constitutional osteoarthritis is due to age growth, toils away, and cause osteoarthrosis degenerative change, laxity of ligament, muscle strength declines, and the stability in joint is affected, surrounding's formation bony spur in joint, thus causes arthritis.Secondary osteoarthrosis many because of articular trauma, developmental disorder etc. cause that articular surface is uneven, unbalance stress and cause primary disease.The method of current state internal therapy bone matrix hyperplasia has a lot, as galvanoiontophoresis method, ultraviolet therapy, western medicine, operative treatment etc., though these therapys energy respite pain, there is treatment has limitation, curative effect inadequate more, and focus still exists.
Bone matrix hyperplasia belongs to " arthromyodynia " category of the traditional Chinese medical science, also known as " rheumatism involving the bone ".The traditional Chinese medical science thinks that primary disease is relevant with wound, strain, obstruction of collaterals by blood stasis, the damp that is affected by the cold, phlegm resistance, caused by liver and kidney deficiency etc.
Summary of the invention
The invention discloses a kind of Chinese medicine composition for the treatment of hyperosteogeny, this Chinese medicine composition has blood circulation promoting and blood stasis dispelling, effect of dredging the meridian, and treatment hyperosteogeny, good effect, instant effect, relapse rate is low.
The present invention adopts following technical scheme.
Treat a Chinese medicine composition for hyperosteogeny, obtained by following weight portion traditional Chinese medicinal material raw materials: Flos Carthami 1-20 part, Herba seu Radix Cirsii Japonici (Radix Saussureae cordifoliae) 1-20 part, Radix Cynanchi Auriculati 1-20 part, Radix Rehmanniae Preparata 1-30 part, muscles and bones are fallen apart 1-40 part, Radix Clematidis 1-30 part, Radix Ampelopsis delavayanae 1-30 part, Pheretima 1-20 part, Corii Cuon alpini Camphor tree 1-40 part, Yunnan Rhizoma Et Radix Notopterygii 1-20 part, Stahlianthus hainanensis (Hayata) T. L. Wu 1-20 part, Radix ardisiae villosae 1-30 part, SANYE lotus 1-100 part, Lycopodium fargesii 1-20 part, bracketplant 1-30 part, Radix Glycyrrhizae 1-20 part.
Preferably, the Chinese medicine composition of above-mentioned treatment hyperosteogeny, is obtained by following weight portion traditional Chinese medicinal material raw materials: Flos Carthami 1-10 part, Herba seu Radix Cirsii Japonici (Radix Saussureae cordifoliae) 5-15 part, Radix Cynanchi Auriculati 1-10 part, Radix Rehmanniae Preparata 1-20 part, muscles and bones are fallen apart 1-30 part, Radix Clematidis 1-20 part, Radix Ampelopsis delavayanae 1-20 part, Pheretima 1-10 part, Corii Cuon alpini Camphor tree 1-30 part, Yunnan Rhizoma Et Radix Notopterygii 1-10 part, Stahlianthus hainanensis (Hayata) T. L. Wu 1-10 part, Radix ardisiae villosae 1-20 part, SANYE lotus 1-90 part, Lycopodium fargesii 1-10 part, bracketplant 1-20 part, Radix Glycyrrhizae 1-10 part.
Further preferably, the Chinese medicine composition of above-mentioned treatment hyperosteogeny, is obtained by following weight portion traditional Chinese medicinal material raw materials: Flos Carthami 3-6 part, Herba seu Radix Cirsii Japonici (Radix Saussureae cordifoliae) 10-15 part, Radix Cynanchi Auriculati 5-10 part, Radix Rehmanniae Preparata 1-15 part, muscles and bones are fallen apart 10-30 part, Radix Clematidis 1-10 part, Radix Ampelopsis delavayanae 10-20 part, Pheretima 5-10 part, Corii Cuon alpini Camphor tree 10-30 part, Yunnan Rhizoma Et Radix Notopterygii 3-10 part, Stahlianthus hainanensis (Hayata) T. L. Wu 3-10 part, Radix ardisiae villosae 5-20 part, SANYE lotus 10-90 part, Lycopodium fargesii 3-10 part, bracketplant 5-20 part, Radix Glycyrrhizae 5-10 part.
According to curative effect of medication, filter out 3 most preferred Chinese prescriptions:
(1) 3 parts, Flos Carthami, Herba seu Radix Cirsii Japonici (Radix Saussureae cordifoliae) 11 parts, Radix Cynanchi Auriculati 6 parts, Radix Rehmanniae Preparata 10 parts, loose 15 parts of muscles and bones, Radix Clematidis 5 parts, Radix Ampelopsis delavayanae 10 parts, Pheretima 5 parts, Corii Cuon alpini Camphor tree 15 parts, Yunnan Rhizoma Et Radix Notopterygii 4 parts, Stahlianthus hainanensis (Hayata) T. L. Wu 3 parts, Radix ardisiae villosae 9 parts, 20 parts, SANYE lotus, Lycopodium fargesii 6 parts, bracketplant 6 parts, 5 parts, Radix Glycyrrhizae;
(2) 4 parts, Flos Carthami, Herba seu Radix Cirsii Japonici (Radix Saussureae cordifoliae) 12 parts, Radix Cynanchi Auriculati 7 parts, Radix Rehmanniae Preparata 13 parts, loose 20 parts of muscles and bones, Radix Clematidis 6 parts, Radix Ampelopsis delavayanae 12 parts, Pheretima 7 parts, Corii Cuon alpini Camphor tree 20 parts, Yunnan Rhizoma Et Radix Notopterygii 5 parts, Stahlianthus hainanensis (Hayata) T. L. Wu 6 parts, Radix ardisiae villosae 10 parts, 30 parts, SANYE lotus, Lycopodium fargesii 7 parts, bracketplant 10 parts, 7 parts, Radix Glycyrrhizae;
(3) 5 parts, Flos Carthami, Herba seu Radix Cirsii Japonici (Radix Saussureae cordifoliae) 14 parts, Radix Cynanchi Auriculati 8 parts, Radix Rehmanniae Preparata 15 parts, loose 25 parts of muscles and bones, Radix Clematidis 9 parts, Radix Ampelopsis delavayanae 15 parts, Pheretima 8 parts, Corii Cuon alpini Camphor tree 26 parts, Yunnan Rhizoma Et Radix Notopterygii 6 parts, Stahlianthus hainanensis (Hayata) T. L. Wu 9 parts, Radix ardisiae villosae 15 parts, 60 parts, SANYE lotus, Lycopodium fargesii 9 parts, bracketplant 15 parts, 8 parts, Radix Glycyrrhizae.
According to Chinese medicine Historical Data Data About, above-mentioned Chinese crude drug has following pharmacologically active and function cures mainly:
Flos Carthami, promoting blood circulation to restore menstrual flow, blood stasis removing pain relieving.Control amenorrhea ， mass in the abdomen, difficult labour, stillborn fetus, disease that postpartum lochia can't go, blood stasis are had a pain, carbuncle, injury from falling down.
Herba seu Radix Cirsii Japonici (Radix Saussureae cordifoliae), cold relieving, dissipating blood stasis, analgesia.Cure mainly headache due to common cold, arthralgia, impairment caused by overstrain.
Radix Cynanchi Auriculati, invigorating the liver and kidney; Bone and muscle strengthening; Benefiting essence-blood; Strengthening the spleen to promote digestion; Detoxification sore treatment.Main soreness of the waist and knees; Impotence and seminal emission; Dizziness and tinnitus; Palpitation and insomnia; Inappetence; Infantile malnutrition; Puerperal, milk was rare; Sore, carbuncle and painful swelling.
Radix Rehmanniae Preparata, nourishing YIN and supplementing blood, beneficial essence fills out marrow.For the hepatic and renal YIN deficiency, soreness of the waist and knees, osteopyrexia and fever, night sweat is passed out semen, and interior-heat is quenched one's thirst, blood deficiency and yellow complexion, severe palpitation, menoxenia, and metrostaxis is dizzy, tinnitus, early whitening of beard and hair.
Muscles and bones is fallen apart, wind-damp dispelling, bone and muscle strengthening, pain relieving.For vasculitis, rheumatic arthritis, bones and muscles pain, lumbago, stomachache, spits blood.
Radix Clematidis, expelling wind and removing dampness; Removing obstruction in the collateral to relieve pain.Cure mainly rheumatic arthralgia; Numb limbs and tense tendons; The contracture of muscle arteries and veins; Joint stuffiness; Beriberi swells and ache; Malaria; Bone is choked with sobs larynx; And control phlegm retention and gather.
Radix Ampelopsis delavayanae, dispelling, collateral-activating, subduing swelling and detoxicating, hemostasia and promoting granulation.Dispelling the wind and dampness pathogens arthralgia pain, traumatic injury, fracture, carbuncle furuncle.
Pheretima, heat clearing away is calmed the frightened, and dredging collateral, relievings asthma, diuresis.For unconsciousness due to high fever, infantile convulsion is twitched, arthralgia, numb limbs and tense tendons, hemiplegia, dyspnea and cough due to lung-heat, oliguria edema, hypertension.
Corii Cuon alpini Camphor tree, promoting flow of QI and blood pain relieving; Wind-damp dispelling.Main stomachache; Stomachache; Dysentery; Diarrhoea; Dysmenorrhea; Rheumatic arthralgia; Traumatic injury.
Yunnan Rhizoma Et Radix Notopterygii, expelling wind and removing dampness; Removing obstruction in the collateral to relieve pain.Main anemofrigid cold; Anemofrigid-damp arthralgia; The contracture of muscle arteries and veins; Headache; Abdominal pain.
Stahlianthus hainanensis (Hayata) T. L. Wu, promoting blood circulation to remove blood stasis, reducing swelling and alleviating pain.For traumatic injury, rheumatic ostalgia, hematemesis and epistaxis, menorrhagia; Worm venom is controlled in external, traumatic hemorrhage.
Radix ardisiae villosae, expelling wind and removing dampness, promoting blood circulation and stopping pain.Dispelling the wind and dampness pathogens pain, treating swelling and pain by traumatic injury, cough is spitted blood, abdominal pain due to cold.
SANYE lotus, clearing away heat-damp and promoting diuresis; Removing obstruction in the collateral to relieve pain.Main pyretic stranguria; Dysuria; Edema; Rheumatic arthralgia; Stomachache; Lumbago; Traumatic injury.
Lycopodium fargesii, expelling wind and removing dampness, relaxing muscles and tendons and activating QI and blood in the collateral.For rheumatic arthritis, muscle spasm, traumatic injury, hypertrophic spondylitis, rheumatoid arthritis.
Bracketplant, preventing phlegm from forming and stopping coughing; Dissipating blood stasis for subsidence of swelling; Heat-clearing and toxic substances removing.Main phlegm-heat cough; Traumatic injury; Fracture; Carbuncle; Hemorrhoid.
Radix Glycyrrhizae, invigorating the spleen and replenishing QI, heat-clearing and toxic substances removing, expelling phlegm for arresting cough, relieving spasm to stop pain, coordinating the actions of various ingredients in a prescription.For weakness of the spleen and stomach, fatigue and weakness, shortness of breath and palpitation, cough with copious phlegm, the anxious pain of gastral cavity abdomen, extremity contraction, carbuncle sore tumefacting virus, cushion toxicity, strong.
Above-mentioned Chinese medicine composition can be prepared into the preparations such as tablet, pill, powder, capsule according to prior art.
Found by clinical application research, the pharmaceutical composition be prepared from by above-mentioned Chinese crude drug obtains satisfied curative effect in treatment hyperosteogeny.Therefore, another object of the present invention is to provide a kind of new medical use, i.e. the application of above-mentioned Chinese medicine composition in preparation treatment hyperosteogeny medicine.
Compatibility of drugs of the present invention is reasonable, has the effects such as expelling wind and activating blood circulation, powerful bone strengthening, dehumidifying cold expelling, treatment hyperosteogeny and complication thereof is had to the effect for the treatment of both the principal and secondary aspects of a disease, and more after do not recur.
Detailed description of the invention
Below in conjunction with specific embodiment, the invention will be further described.It should be noted that, following examples, for explaining the present invention, are not limitation of the present invention.
(1) medicine preparation
the preparation of embodiment 1 medicament capsule of the present invention
Prescription: 3 parts, Flos Carthami, Herba seu Radix Cirsii Japonici (Radix Saussureae cordifoliae) 11 parts, Radix Cynanchi Auriculati 6 parts, Radix Rehmanniae Preparata 10 parts, loose 15 parts of muscles and bones, Radix Clematidis 5 parts, Radix Ampelopsis delavayanae 10 parts, Pheretima 5 parts, Corii Cuon alpini Camphor tree 15 parts, Yunnan Rhizoma Et Radix Notopterygii 4 parts, Stahlianthus hainanensis (Hayata) T. L. Wu 3 parts, Radix ardisiae villosae 9 parts, 20 parts, SANYE lotus, Lycopodium fargesii 6 parts, bracketplant 6 parts, 5 parts, Radix Glycyrrhizae;
Preparation method: the above-mentioned Chinese crude drug taking recipe quantity, dry, be ground into 200 order powder after mix homogeneously, then incapsulate shell, every capsules is equipped with 1g drug powder.
the preparation of embodiment 2 medicament capsule of the present invention
Prescription: 4 parts, Flos Carthami, Herba seu Radix Cirsii Japonici (Radix Saussureae cordifoliae) 12 parts, Radix Cynanchi Auriculati 7 parts, Radix Rehmanniae Preparata 13 parts, loose 20 parts of muscles and bones, Radix Clematidis 6 parts, Radix Ampelopsis delavayanae 12 parts, Pheretima 7 parts, Corii Cuon alpini Camphor tree 20 parts, Yunnan Rhizoma Et Radix Notopterygii 5 parts, Stahlianthus hainanensis (Hayata) T. L. Wu 6 parts, Radix ardisiae villosae 10 parts, 30 parts, SANYE lotus, Lycopodium fargesii 7 parts, bracketplant 10 parts, 7 parts, Radix Glycyrrhizae;
Preparation method: with embodiment 1.
the preparation of embodiment 3 medicament capsule of the present invention
Prescription: 5 parts, Flos Carthami, Herba seu Radix Cirsii Japonici (Radix Saussureae cordifoliae) 14 parts, Radix Cynanchi Auriculati 8 parts, Radix Rehmanniae Preparata 15 parts, loose 25 parts of muscles and bones, Radix Clematidis 9 parts, Radix Ampelopsis delavayanae 15 parts, Pheretima 8 parts, Corii Cuon alpini Camphor tree 26 parts, Yunnan Rhizoma Et Radix Notopterygii 6 parts, Stahlianthus hainanensis (Hayata) T. L. Wu 9 parts, Radix ardisiae villosae 15 parts, 60 parts, SANYE lotus, Lycopodium fargesii 9 parts, bracketplant 15 parts, 8 parts, Radix Glycyrrhizae.
Preparation method: with embodiment 1.
(2) the clinical test of pesticide effectiveness
1, case selection:
Clinical treatment patient 420 example, age 35-68 year, wherein male 286 people, women 134 people, all cases is all the hyperosteogeny that degree is different.
2, Therapeutic Method:
Take the capsule that the embodiment of the present invention 3 is obtained, 3 tablets/time, every day 2 times.20 days courses for the treatment of.2-4 the course for the treatment of is taken according to disease degree.
3, diagnostic criteria:
(1) hyperosteogeny of cervical vertebra:
Clinical manifestation: there are strong sensation, limitation of activity in neck portion, cervical region activity has snap sound, pain is often to shoulder and upper limb radiation, and hands and finger have numbness, electric shock sample to feel, can increase the weight of because cervical region is movable.Different pathological changes involves different parts, just occurs different symptoms, can cause paralysis late period.
Hyperosteogeny of cervical vertebra severe patient also can cause cervical vertebra characteristic of disease hypertension, cardiovascular and cerebrovascular disease, gastritis, angina pectoris, dysphagia etc.
(2) lumbar vertebra hyperosteogeny:
Predilection site, the most common with waist three, waist four.Often occur that lumbar vertebra and lumbar soft tissue are ached clinically, distending pain, stiff and tired sense, even bend over limited.As contiguous root compression, corresponding symptom can be caused, occur local pain, send out stiff, rear neuralgia, numbness etc.As sciatic nerve crush can cause sciatic neuritis, there is suffering limb violent fiber crops pain, causalgia, take out pain, go here and there bitterly, radiate to whole lower limb.
(3) knee joint hyperosteogeny:
Initial stage, the onset slow person gonalgia is not serious, has sustainability dull pain, and when temperature reduces, pain increases the weight of, relevant with climate change, morning comes into play after rising, and walks for a long time, and strenuous exercise or sitting gonalgia when starting to walk that stands up is stiff, take a turn for the better after slightly movable, upper and lower building difficulty, time downstairs, knee joint is felt like jelly, and easily falls down.Pain when having squatted, stiff, time serious, joint aches distending pain, limping is walked, and merge rheumatism patient redness and swelling of joints, deformity, function limitation, stretching activity in the wrong has snap sound, some patients visible joint hydrops, and there are obvious tumefaction, compression phenomena in local.
4, efficacy evaluation: 1. cure: clinical symptoms all disappears.2. effective: clinical symptoms major part disappears or takes a turn for the better.3. invalid: clinical symptoms and sign are without significant change.
5, therapeutic effect: the present invention, to 420 routine patient clinical treatments, cures and follows up a case by regular visits to more than 2 years non-recidivist 347 examples, account for 86.75%; Effective 53 examples, account for 13.25%; Total effective rate reaches 100%.
Model case:
1, grandson so-and-so, female, 42 years old, symptom: neck is uncomfortable, miserable pain; Lumbago, waist limitation of activity, is diagnosed as hyperosteogeny of cervical vertebra and lumbar vertebra hyperosteogeny, ill 8 years, and at many hospital admissions, never radical cure, treat a course for the treatment of with the present invention, symptom obviously alleviates, and two courses for the treatment of cure, and follows up a case by regular visits to 2 years without recurrence.
2, king so-and-so, man, 51 years old, symptom: the gonalgia, when temperature reduces, pain increased the weight of, and X light display shows hyperosteogeny, is diagnosed as knee joint hyperosteogeny and ankle joint hyperosteogeny, treats two courses for the treatment of cure with the present invention, follows up a case by regular visits to 2 years without recurrence.
3, Wei so-and-so, female, 60 years old, symptom: upper and lower building difficulty, time downstairs, knee joint is felt like jelly, time serious, and joint aches distending pain, ankle pain, be diagnosed as knee joint hyperosteogeny and ankle joint hyperosteogeny, many hospitalizes, effect is undesirable, treat three courses for the treatment of with the present invention to cure, follow up a case by regular visits to 2 years without recurrence.
4, Zhao, man, 55 years old, waist hyperosteogeny, waist cannot directly rise, and gnawing pains take no rest, and with after the course for the treatment of of the present invention, pain obviously alleviates, and waist is movable, and after continuing to take two courses for the treatment of, pain is eliminated, waist nimbly and freely, recovery from illness.
5, remaining so-and-so, female, 49 years old, hyperosteogeny of cervical vertebra, shoulder back of the body disease of hand, western medicine was repeatedly invalid, hurt like hell, and with after two courses for the treatment of of the present invention, pain obviously alleviates, and after continuing to take a course for the treatment of, recovery from illness, does not recur so far.
From above-mentioned clinical data, the present invention has good curative effect for treatment hyperosteogeny, and without recurrence.
Claims (8)
1. treat a Chinese medicine composition for hyperosteogeny, it is characterized in that being obtained by following weight portion traditional Chinese medicinal material raw materials: Flos Carthami 1-20 part, Herba seu Radix Cirsii Japonici (Radix Saussureae cordifoliae) 1-20 part, Radix Cynanchi Auriculati 1-20 part, Radix Rehmanniae Preparata 1-30 part, muscles and bones are fallen apart 1-40 part, Radix Clematidis 1-30 part, Radix Ampelopsis delavayanae 1-30 part, Pheretima 1-20 part, Corii Cuon alpini Camphor tree 1-40 part, Yunnan Rhizoma Et Radix Notopterygii 1-20 part, Stahlianthus hainanensis (Hayata) T. L. Wu 1-20 part, Radix ardisiae villosae 1-30 part, SANYE lotus 1-100 part, Lycopodium fargesii 1-20 part, bracketplant 1-30 part, Radix Glycyrrhizae 1-20 part.
2. the Chinese medicine composition for the treatment of hyperosteogeny as claimed in claim 1, is characterized in that being obtained by following weight portion traditional Chinese medicinal material raw materials: Flos Carthami 1-10 part, Herba seu Radix Cirsii Japonici (Radix Saussureae cordifoliae) 5-15 part, Radix Cynanchi Auriculati 1-10 part, Radix Rehmanniae Preparata 1-20 part, muscles and bones are fallen apart 1-30 part, Radix Clematidis 1-20 part, Radix Ampelopsis delavayanae 1-20 part, Pheretima 1-10 part, Corii Cuon alpini Camphor tree 1-30 part, Yunnan Rhizoma Et Radix Notopterygii 1-10 part, Stahlianthus hainanensis (Hayata) T. L. Wu 1-10 part, Radix ardisiae villosae 1-20 part, SANYE lotus 1-90 part, Lycopodium fargesii 1-10 part, bracketplant 1-20 part, Radix Glycyrrhizae 1-10 part.
3. the Chinese medicine composition for the treatment of hyperosteogeny as claimed in claim 2, is characterized in that being obtained by following weight portion traditional Chinese medicinal material raw materials: Flos Carthami 3-6 part, Herba seu Radix Cirsii Japonici (Radix Saussureae cordifoliae) 10-15 part, Radix Cynanchi Auriculati 5-10 part, Radix Rehmanniae Preparata 1-15 part, muscles and bones are fallen apart 10-30 part, Radix Clematidis 1-10 part, Radix Ampelopsis delavayanae 10-20 part, Pheretima 5-10 part, Corii Cuon alpini Camphor tree 10-30 part, Yunnan Rhizoma Et Radix Notopterygii 3-10 part, Stahlianthus hainanensis (Hayata) T. L. Wu 3-10 part, Radix ardisiae villosae 5-20 part, SANYE lotus 10-90 part, Lycopodium fargesii 3-10 part, bracketplant 5-20 part, Radix Glycyrrhizae 5-10 part.
4. the Chinese medicine composition for the treatment of hyperosteogeny as claimed in claim 3, is characterized in that being obtained by following weight portion traditional Chinese medicinal material raw materials: 3 parts, Flos Carthami, Herba seu Radix Cirsii Japonici (Radix Saussureae cordifoliae) 11 parts, Radix Cynanchi Auriculati 6 parts, Radix Rehmanniae Preparata 10 parts, loose 15 parts of muscles and bones, Radix Clematidis 5 parts, Radix Ampelopsis delavayanae 10 parts, Pheretima 5 parts, Corii Cuon alpini Camphor tree 15 parts, Yunnan Rhizoma Et Radix Notopterygii 4 parts, Stahlianthus hainanensis (Hayata) T. L. Wu 3 parts, Radix ardisiae villosae 9 parts, 20 parts, SANYE lotus, Lycopodium fargesii 6 parts, bracketplant 6 parts, 5 parts, Radix Glycyrrhizae.
5. the Chinese medicine composition for the treatment of hyperosteogeny as claimed in claim 3, is characterized in that being obtained by following weight portion traditional Chinese medicinal material raw materials: 4 parts, Flos Carthami, Herba seu Radix Cirsii Japonici (Radix Saussureae cordifoliae) 12 parts, Radix Cynanchi Auriculati 7 parts, Radix Rehmanniae Preparata 13 parts, loose 20 parts of muscles and bones, Radix Clematidis 6 parts, Radix Ampelopsis delavayanae 12 parts, Pheretima 7 parts, Corii Cuon alpini Camphor tree 20 parts, Yunnan Rhizoma Et Radix Notopterygii 5 parts, Stahlianthus hainanensis (Hayata) T. L. Wu 6 parts, Radix ardisiae villosae 10 parts, 30 parts, SANYE lotus, Lycopodium fargesii 7 parts, bracketplant 10 parts, 7 parts, Radix Glycyrrhizae.
6. the Chinese medicine composition for the treatment of hyperosteogeny as claimed in claim 3, is characterized in that being obtained by following weight portion traditional Chinese medicinal material raw materials: 5 parts, Flos Carthami, Herba seu Radix Cirsii Japonici (Radix Saussureae cordifoliae) 14 parts, Radix Cynanchi Auriculati 8 parts, Radix Rehmanniae Preparata 15 parts, loose 25 parts of muscles and bones, Radix Clematidis 9 parts, Radix Ampelopsis delavayanae 15 parts, Pheretima 8 parts, Corii Cuon alpini Camphor tree 26 parts, Yunnan Rhizoma Et Radix Notopterygii 6 parts, Stahlianthus hainanensis (Hayata) T. L. Wu 9 parts, Radix ardisiae villosae 15 parts, 60 parts, SANYE lotus, Lycopodium fargesii 9 parts, bracketplant 15 parts, 8 parts, Radix Glycyrrhizae.
7. the Chinese medicine composition of the treatment hyperosteogeny as described in as arbitrary in claim 1-6, is characterized in that: described Chinese medicine composition can be prepared into tablet, pill, powder or capsule.
8. the application of the Chinese medicine composition as described in as arbitrary in claim 1-6 in preparation treatment hyperosteogeny medicine.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410650325.4A CN104306845A (en) | 2014-11-17 | 2014-11-17 | Traditional Chinese medicine composition for treating hyperosteogeny and application thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410650325.4A CN104306845A (en) | 2014-11-17 | 2014-11-17 | Traditional Chinese medicine composition for treating hyperosteogeny and application thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104306845A true CN104306845A (en) | 2015-01-28 |
Family
ID=52362254
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410650325.4A Pending CN104306845A (en) | 2014-11-17 | 2014-11-17 | Traditional Chinese medicine composition for treating hyperosteogeny and application thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104306845A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018201578A1 (en) * | 2017-04-30 | 2018-11-08 | 朱秀青 | Medicated hare or rabbit meat |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101721497A (en) * | 2008-10-22 | 2010-06-09 | 刘运波 | Traditional Chinese medicine for treating bone hyperplasia |
-
2014
- 2014-11-17 CN CN201410650325.4A patent/CN104306845A/en active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101721497A (en) * | 2008-10-22 | 2010-06-09 | 刘运波 | Traditional Chinese medicine for treating bone hyperplasia |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018201578A1 (en) * | 2017-04-30 | 2018-11-08 | 朱秀青 | Medicated hare or rabbit meat |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102908442B (en) | Composition for treating traumatic injuries and medicinal liquor thereof | |
| CN104147288A (en) | Traditional Chinese medicine with the effects of soothing channels and invigorate blood circulation | |
| CN104189871A (en) | Medicated wine for treating osteoproliferation | |
| CN102309723B (en) | Traditional Chinese medicine composition for treating arthralgia and preparation method of ointment thereof | |
| CN103285200B (en) | Traditional Chinese medicine for treating multiple osteopathies | |
| CN101450197A (en) | Traditional Chinese medicine for treating rheumatism, rheumatoid disease | |
| CN103463580B (en) | Chinese medicine ointment for treating pain of muscles, bones and joints and preparation method thereof | |
| CN1861171A (en) | Method for preparing traditional Chinese medicine to treat apoplexia hemiplegia and said medicine | |
| CN104324093A (en) | Traditional Chinese medicine composition for treating hyperosteogeny and preparation method of traditional Chinese medicine composition | |
| CN103565969A (en) | Traditional Chinese medicine composition for treating soft tissue injury and fracture | |
| CN102600256A (en) | Traditional Chinese medical composition for treatment of traumatic injury | |
| CN103735647A (en) | Medicated wine for treating chronic infectious arthritis | |
| CN104306845A (en) | Traditional Chinese medicine composition for treating hyperosteogeny and application thereof | |
| CN104435499B (en) | A kind of red ointment rehabilitation paste and preparation method thereof | |
| CN105687944A (en) | Traditional Chinese medicine composition for treating cervical spondylosis and lumbar spondylosis | |
| CN105663897A (en) | Traditional Chinese medicine composition for treating zoster | |
| CN104173689A (en) | Medicine for treating traumatic injury, lumbar disc herniation and scapulohumeral periarthritis and preparation method of medicine | |
| CN101810747B (en) | Chinese medicinal preparation for treating cervical spondylosis and lumbar disc herniation | |
| CN105250933B (en) | A kind of preparation method of the 36-flavor Glutinous Chinese medicine composition to activate blood circulation and disperse blood clots and its paste | |
| CN104606313A (en) | Traditional Chinese medicinal ointment for treating osteoarticular diseases and bone fractures | |
| CN103083489B (en) | Traditional Chinese medicine wine for treating lumbar spondylosis, cervical spondylosis, early osteoproliferation and old wounds | |
| CN108030870A (en) | It is a kind of to treat protrusion of lumber intervertebral disc and the plaster of bone fracture and preparation method thereof | |
| CN106421255A (en) | Topical traditional Chinese composition and its application | |
| CN105687784A (en) | Traditional Chinese medicine for oral administration and plaster for treating cervical vertebra, scapulohumeral periarthritis and lumbar disc herniation | |
| CN103977094B (en) | A kind of Chinese medicine treating spondylitis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| CB03 | Change of inventor or designer information |
Inventor after: Wu Shaoqin Inventor before: Cui Hefang |
|
| CB03 | Change of inventor or designer information | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150128 |
|
| RJ01 | Rejection of invention patent application after publication |